Navigation Links
West Nile virus' spread through nerve cells linked to serious complication
Date:10/18/2007

Oct. 18, 2007 -- Scientists believe they have found an explanation for a puzzling and serious complication of West Nile virus infection.

Researchers at Washington University School of Medicine in St. Louis and Utah State University showed that West Nile virus can enter a nerve cell, replicate and move on to infect other nearby nerve cells. Viruses traveling this infectious pathway can break into the central nervous system, triggering a condition known as acute flaccid paralysis that leaves one or more limbs limp and unresponsive. No treatment is currently available for this complication. Patients must undergo rehabilitation to relearn to use the affected limb.

Injection of a West Nile virus antibody, created by Washington University and a private biotechnology firm, blocked the complication in laboratory animals. The results appear online in the Proceedings of the National Academy of Sciences.

Preliminary data suggests there will be approximately 4,000 to 5,000 severe West Nile virus infections in the United States in 2007. First isolated in Africa in 1937, West Nile spread to the Middle East, Europe, and Asia before arriving in the United States in 1999. Most infections with the virus are mild or symptom-free, but infections in people with weakened immune systems and those over 50 sometimes lead to serious complications or death.

Senior author Michael Diamond, M.D., Ph.D., associate professor of molecular microbiology, of pathology and immunology and of medicine, began the new study because of a puzzling contrast in the ways West Nile virus infection affects the central nervous system.

One form of infection, encephalitis, causes inflammation of the brain and leads to fever, headaches, weakness and seizures. It is much more likely to occur in patients who are elderly or have weakened or suppressed immune systems. The other form of infection, acute flaccid paralysis, strikes patients with weakened immune systems but also affects a significant number of patients with healthy immune systems.

"Based on our mouse model of West Nile virus infection, we already knew that the most likely cause of encephalitis was virus in the blood breaking through the blood-brain barrier to infect the brain," says Diamond. "But the epidemiological contrast suggested to us that there might be a fundamentally different infectious mechanism behind paralysis."

In experiments led by Melanie Samuel, a graduate student in Diamond's lab, researchers found that West Nile virus could spread in either direction along the branches of neurons in culture. Samuel used an electron microscope to observe the virus traveling down nerve branches in small capsules known as vesicles. Researchers also found infected nerve cells released virus.

To test their results in an animal model, scientists used a suture to close off the sciatic nerve in hamsters. Then they injected West Nile virus directly into the nerve, either above the suture (i.e., closer to the spine) or below it. Animals who received an injection below the suture came down with encephalitis. But those whose injections were above the suture developed both encephalitis and paralysis because the virus was able to follow the sciatic nerve back to the central nervous system.

An untreated human patient's chances of developing flaccid paralysis from West Nile may come down to a roll of the dice, Diamond speculates. To break through the blood-brain barrier and cause encephalitis, high levels of the virus have to build up in the blood. In the elderly or patients with weakened immune systems, West Nile is able to replicate relatively freely in areas like the skin and lymph tissues, providing additional copies of the virus that build up in the blood.

"Paralysis might not require such high levels of infection," he theorizes. "What may happen instead is if a mosquito bites you and the virus is able to replicate in the vicinity of a nerve, by the time the immune system has cleared the infection in the skin, a small amount of virus may already be following the nerve back to the spinal cord. Unless you have a robust antibody response, you're probably not going to clear that fast enough, and you might get paralysis."

When scientists injected a therapeutic antibody the day after the viral injection, it blocked both encephalitis and paralysis. The antibody, developed by Washington University and Macrogenics Inc., has been licensed to Macrogenics for commercial development and is in early clinical trials in humans.

"We already knew the antibody could block encephalitis," notes Diamond, in whose laboratory the antibody was originally developed. "The levels of antibody in the central nervous system are relatively low compared to the rest of the body, but they're still high enough to block paralysis."

Diamond plans follow-up studies to see how long after infection the antibodies can be injected and still retain their protective effect against paralysis. He also plans to test whether the virus is sitting back and passively letting the nerve cell move it along or actively pushing itself forward by manipulating nerve cell physiology.

Diamond and co-author John D. Morrey have a financial interest in the antibody that is regulated in accordance with Washington University's conflict-of-interest policies.


'/>"/>

Contact: Michael C. Purdy
purdym@wustl.edu
314-286-0122
Washington University in St. Louis
Source:Eurekalert

Related biology news :

1. Association of herpesvirus with lung disorder questioned
2. Topical treatment shown to inhibit HIV and herpes simplex virus infection
3. Elusive HIV shape change revealed; Key clue to how virus infects cells
4. Scientists Replicate Hepatitis C Virus in Laboratory
5. Newly discovered virus linked to childhood lung disorders and Kawasaki disease
6. Live Recombinant Adenovirus Vaccine Technique Explored
7. Marburg virus disease in Angola - update
8. Study: Soap And Water Work Best In Ridding Hands Of Disease Viruses
9. Studies reveal methods viruses use to sidestep immune system
10. Mayo Clinic Researchers Create Obedient Virus; First Step To Use Measles Virus Against Cancer
11. Norovirus, AIDS vaccine and Hepatitis Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/11/2016)... PUNE, India , March 11, 2016 ... to a new market research report "Image Recognition Market ... by Application (Marketing and Advertising), by Deployment Type (On-Premises ... Global Forecast To 2022", published by MarketsandMarkets, the global ... in 2015 to USD 29.98 Billion by 2020, at ...
(Date:3/9/2016)... , March 9, 2016 ... identified that more than 23,000 public service employees either ... been receiving their salary unlawfully.    --> ... government identified that more than 23,000 public service employees ... had been receiving their salary unlawfully.    --> ...
(Date:3/3/2016)... MONTEREY, Calif. , March 3, 2016 /PRNewswire/ ... Partner, launched this week highlighting advancements in flexible, ... – a record setting attendance - have gathered ... in this fast-growing field of electronics. The Flex ... a focal point for companies, R&D organizations, and ...
Breaking Biology News(10 mins):
(Date:4/27/2016)... Columbia , April 27, 2016 ... "NanoStruck") (CSE: NSK) (OTCPink: NSKQB) ( Frankfurt ... Anschluss an ihre Pressemitteilung vom 13. August 2015 ... hat, ihre Finanzen um zusätzliche 200.000.000 Einheiten auf ... Kanadische Dollar zu bringen. Davon wurden 157.900.000 Einheiten ...
(Date:4/27/2016)... ... 2016 , ... PathSensors, Inc., a leading environmental testing company, ... assist PathSensors in expanding the use of the company’s CANARY® technology in the ... for the detection of harmful pathogens, including a number of bacteria, viruses, toxins, ...
(Date:4/27/2016)... 27, 2016 MedDay, a biotechnology company ... the appointment of Catherine Moukheibir as Chairman of its Board ... Jean Jacques Garaud , who contributed to the rapid ... immediately. Catherine started her career in strategy consulting ... London .  She held C-Suite level roles ...
(Date:4/26/2016)... ... April 26, 2016 , ... The European Patent Office ... as one of three finalists for the European Inventor Award 2016 in the category ... will be announced at a ceremony in Lisbon on June 9th. , The human ...
Breaking Biology Technology: